Jun 18, 2021 09:51 PM (GMT+8) · EqualOcean
Today, Huaxi Biotechnology (Tianjin) Co., Ltd., a wholly-owned subsidiary of Huaxi biology, was officially put into operation. Tianjin plant plans to build 64 pilot production lines, and the overall capacity of bioactive materials is planned to reach 1000 tons, including 660 tons of hyaluronic acid raw material and 660 tons ϒ- A variety of bioactive substances, such as aminobutyric acid and icodonin, have been put into production.